Nestlé faces heat for sponsoring breastmilk substitute study in India
India’s apex medical research authority is calling for the end to a Nestlé sponsored study on breastmilk substitutes, arguing it violates local and international laws on marketing of infant formula.
This content was published on
3 minutes
swissinfo.ch/jdp
The Times of IndiaExternal link reported on Sunday that the Indian Council for Medical Research (ICMR) has concluded that Nestlé’s sponsorship of a five-hospital study on infant milk substitutes violates India’s Infant Milk Substitutes ActExternal link.
The law forbids producers or suppliers of breastmilk substitutes from providing financial support to health workers or associations caring for babies or pregnant women including for research.
The Breastfeeding Promotion Network of India (BPNI), responsible for monitoring compliance with the Act, brought the study to the attention of the Indian health ministry and ICMR on July 17. The Clinical Trial Registry lists Nestlé India as the primary sponsor of the study called “Multicentric Observational Study to Observe Growth in Preterm hospitalized infants.”
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
In a press releaseExternal link in early August, Arun Gupta of BPNI argued that Nestlé’s actions are “a gross and blatant violation of the IMS Act.” He demanded strict action by the authorities and said the violation amounts to a criminal offence.
According to the Times of India, two other cases of Nestle-sponsored clinical trials were identified on August 26.
Science or promotion?
In a written statement, a Nestlé spokesperson told swissinfo.ch that “Clinical studies for the purpose of scientific information are not prohibited by legislation in India.” The company adds that the law in India only prohibits financial support if it is for the purpose of promoting the use of infant milk substitutes, feeding bottles and infant foods.
“The objective of the clinical studies in question have been to encourage science-based research. The studies are institution-based studies and all Institutional Ethics Committee approvals have been obtained from the participating sites,” said the spokesperson.
The company also says that no infant formula products were provided to the concerned hospitals, nor were Nestlé products promoted in the hospitals.
Vevey-based Nestlé is a leading manufacturer of infant milk substitutes and infant foods. On its websiteExternal link, the company says they are committedExternal link to comply with the International Code of Marketing of Breastmilk Substitutes “as implemented locally by governments.”
The Nestlé India websiteExternal link says the company complies with Indian law including the provisions on not providing financial incentives to health workers for the purpose of promoting infant milk substitutes.
The Breastfeeding Promotion Network of India pointed the finger at weak enforcement mechanisms in India that have allowed Nestlé to sponsor the studies.
This content was published on
Nemo brought the Eurovision Song Contest to Switzerland with a victory on Saturday evening in Malmö, Sweden. It is Switzerland's third victory in the history of the music contest.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Nestlé’s controversial bestseller
This content was published on
Nestlé’s infant formula was developed in the 1800s and went on to become a huge success. But in the 1970s it was the reason the company came under attack. The formula was said to cause infant illness, even death. An international campaign to boycott Nestlé was launched. A Swiss group joined the campaign, going even…
Nestlé to offer blockchain milk tracing system to consumers
This content was published on
The Swiss company has partnered with the OpenSC “blockchain-enabled” digital systemExternal link built by WWF Australia and Boston Consulting Group Digital Ventures to allow anyone in the world to trace data. Consumers can scan a QR code on the product in a shop to check where ingredients were sourced and follow them though the supply…
This content was published on
The Chinese National Development and Reform Commission (NDRC) announced that it was charging the companies a total of $110 million (CHF102 million) following a four-month antitrust probe. The penalised firms are Mead Johnson Nutrition, Danone, Fonterra, Abbott Laboratories, FrieslandCampina and Biostime International Holdings. In a statement, published on Wednesday, the NDRC said that the fines…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.